Arbutus Total Assets vs Cash And Short Term Investments Analysis

ABUS Stock  USD 3.64  0.12  3.19%   
Arbutus Biopharma financial indicator trend analysis is way more than just evaluating Arbutus Biopharma Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arbutus Biopharma Corp is a good investment. Please check the relationship between Arbutus Biopharma Total Assets and its Cash And Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arbutus Biopharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Total Assets vs Cash And Short Term Investments

Total Assets vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Arbutus Biopharma Corp Total Assets account and Cash And Short Term Investments. At this time, the significance of the direction appears to have strong relationship.
The correlation between Arbutus Biopharma's Total Assets and Cash And Short Term Investments is 0.75. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Arbutus Biopharma Corp, assuming nothing else is changed. The correlation between historical values of Arbutus Biopharma's Total Assets and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Arbutus Biopharma Corp are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Total Assets i.e., Arbutus Biopharma's Total Assets and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.75
Relationship DirectionPositive 
Relationship StrengthSignificant

Total Assets

Total assets refers to the total amount of Arbutus Biopharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Arbutus Biopharma Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Arbutus Biopharma Corp balance sheet. This account contains Arbutus Biopharma investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Arbutus Biopharma Corp fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Arbutus Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arbutus Biopharma Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arbutus Biopharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
At this time, Arbutus Biopharma's Issuance Of Capital Stock is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 2.32 in 2024, whereas Tax Provision is likely to drop 0.00 in 2024.

Arbutus Biopharma fundamental ratios Correlations

-0.130.081.00.14-0.73-0.040.760.970.40.75-0.090.320.10.120.97-0.10.270.970.010.74-0.220.210.650.970.9
-0.130.88-0.140.00.14-0.57-0.13-0.28-0.330.230.220.520.720.51-0.250.380.08-0.10.280.240.02-0.37-0.41-0.210.01
0.080.880.050.030.07-0.61-0.01-0.09-0.260.40.220.660.810.640.00.250.230.160.430.4-0.11-0.09-0.050.020.24
1.0-0.140.050.14-0.74-0.030.770.960.430.75-0.090.310.090.110.95-0.080.270.950.010.74-0.230.190.630.950.9
0.140.00.030.140.14-0.67-0.1-0.010.070.46-0.30.560.340.620.060.420.280.10.610.47-0.18-0.480.020.02-0.13
-0.730.140.07-0.740.14-0.17-0.99-0.7-0.24-0.59-0.11-0.050.120.33-0.69-0.09-0.24-0.660.31-0.580.24-0.25-0.37-0.7-0.67
-0.04-0.57-0.61-0.03-0.67-0.170.090.170.39-0.50.0-0.93-0.9-0.830.06-0.71-0.27-0.06-0.84-0.510.10.550.220.04-0.01
0.76-0.13-0.010.77-0.1-0.990.090.720.230.630.080.14-0.03-0.250.730.130.280.7-0.20.62-0.270.260.430.730.72
0.97-0.28-0.090.96-0.01-0.70.170.720.420.56-0.10.11-0.08-0.070.97-0.290.130.94-0.140.55-0.120.290.660.970.88
0.4-0.33-0.260.430.07-0.240.390.230.420.26-0.31-0.24-0.41-0.010.33-0.40.230.27-0.220.25-0.290.310.430.280.31
0.750.230.40.750.46-0.59-0.50.630.560.26-0.060.660.450.520.640.380.50.730.281.0-0.39-0.070.410.630.64
-0.090.220.22-0.09-0.3-0.110.00.08-0.1-0.31-0.06-0.020.06-0.13-0.160.16-0.04-0.08-0.08-0.040.040.16-0.17-0.09-0.1
0.320.520.660.310.56-0.05-0.930.140.11-0.240.66-0.020.930.820.230.620.420.330.830.66-0.25-0.410.020.250.34
0.10.720.810.090.340.12-0.9-0.03-0.08-0.410.450.060.930.780.020.570.280.150.80.45-0.11-0.42-0.170.060.23
0.120.510.640.110.620.33-0.83-0.25-0.07-0.010.52-0.130.820.780.040.40.360.170.760.53-0.22-0.360.040.020.11
0.97-0.250.00.950.06-0.690.060.730.970.330.64-0.160.230.020.04-0.220.210.98-0.040.63-0.170.30.710.990.88
-0.10.380.25-0.080.42-0.09-0.710.13-0.29-0.40.380.160.620.570.4-0.220.2-0.150.470.39-0.08-0.45-0.29-0.21-0.11
0.270.080.230.270.28-0.24-0.270.280.130.230.5-0.040.420.280.360.210.20.230.270.5-0.98-0.280.240.190.2
0.97-0.10.160.950.1-0.66-0.060.70.940.270.73-0.080.330.150.170.98-0.150.230.010.72-0.170.250.670.970.89
0.010.280.430.010.610.31-0.84-0.2-0.14-0.220.28-0.080.830.80.76-0.040.470.270.010.28-0.13-0.39-0.1-0.030.03
0.740.240.40.740.47-0.58-0.510.620.550.251.0-0.040.660.450.530.630.390.50.720.28-0.39-0.070.390.620.63
-0.220.02-0.11-0.23-0.180.240.1-0.27-0.12-0.29-0.390.04-0.25-0.11-0.22-0.17-0.08-0.98-0.17-0.13-0.390.21-0.26-0.15-0.15
0.21-0.37-0.090.19-0.48-0.250.550.260.290.31-0.070.16-0.41-0.42-0.360.3-0.45-0.280.25-0.39-0.070.210.660.250.32
0.65-0.41-0.050.630.02-0.370.220.430.660.430.41-0.170.02-0.170.040.71-0.290.240.67-0.10.39-0.260.660.630.63
0.97-0.210.020.950.02-0.70.040.730.970.280.63-0.090.250.060.020.99-0.210.190.97-0.030.62-0.150.250.630.89
0.90.010.240.9-0.13-0.67-0.010.720.880.310.64-0.10.340.230.110.88-0.110.20.890.030.63-0.150.320.630.89
Click cells to compare fundamentals

Arbutus Biopharma Account Relationship Matchups

Arbutus Biopharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets105.5M137.1M204.5M195.4M144.4M124.4M
Other Current Liab253K5.8M7.3M20.5M9.9M10.4M
Total Current Liabilities7.8M9.5M11.2M32.9M22.5M23.6M
Total Stockholder Equity72.7M102.0M169.4M136.9M106.0M93.5M
Property Plant And Equipment Net11.4M9.3M8.1M6.8M6.1M4.8M
Net Debt(28.4M)(49.3M)(106.7M)(28.6M)(17.6M)(18.4M)
Retained Earnings(970.1M)(1.0B)(1.1B)(1.2B)(1.3B)(1.2B)
Cash31.8M52.3M109.3M30.8M26.3M39.9M
Non Current Assets Total11.7M9.4M43.8M44.3M12.4M11.8M
Non Currrent Assets Other293K44K61K103K92.7K88.1K
Cash And Short Term Investments90.8M123.3M155.3M146.9M126.0M73.6M
Net Receivables1.2M1.3M899K1.4M1.8M1.3M
Common Stock Total Equity898.5M985.9M1.3B1.3B1.5B1.6B
Common Stock Shares Outstanding57.1M75.8M106.2M150.9M166.0M174.3M
Short Term Investments59.0M71.0M46.0M116.1M99.7M104.7M
Liabilities And Stockholders Equity105.5M137.1M204.5M195.4M144.4M124.4M
Non Current Liabilities Total25.0M25.6M23.8M25.7M15.9M25.0M
Other Current Assets1.8M6.2M8.9M2.9M4.2M4.5M
Other Stockholder Equity55.2M60.8M65.5M72.4M81.3M85.3M
Total Liab32.8M35.1M35.0M58.6M38.4M31.0M
Property Plant And Equipment Gross11.4M9.3M8.1M6.8M18.0M18.9M
Total Current Assets93.8M127.7M160.7M151.1M132.0M76.6M
Common Stock898.5M985.9M1.3B1.3B1.3B1.4B
Other Liab21.9M23.0M21.6M23.9M27.5M18.6M
Net Tangible Assets(64.5M)(47.4M)169.4M136.9M157.4M165.2M
Accounts Payable2.4M3.0M3.2M3.5M3.2M2.5M
Retained Earnings Total Equity(970.1M)(1.0B)(1.1B)(1.2B)(1.1B)(1.0B)
Preferred Stock Total Equity49.8M126.1M137.3M149.4M171.8M180.4M
Accumulated Other Comprehensive Income(48.2M)(48.2M)(48.3M)(50.5M)(48.4M)(46.0M)
Property Plant Equipment8.7M6.9M6.0M5.1M5.8M4.5M
Capital Surpluse55.2M60.8M65.5M72.4M83.3M53.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arbutus Stock Analysis

When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.